secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001641172-25-011732
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health board launches national CEO search; Vuppalanchi interim
-------------------------------------------------------------------

- Board initiates a national search for a new CEO to succeed current CEO Dr. Deepika Vuppalanchi.
- Dr. Vuppalanchi will serve as interim CEO until a successor is appointed.
- Co-founder Vuppalanchi is expected to remain on the leadership team post-transition.
- Transition is described as a strategic succession plan for next growth phase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000164117225011732/0001641172-25-011732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000164117225011732/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer